financetom
Business
financetom
/
Business
/
Comerica Q3 Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Comerica Q3 Earnings, Revenue Rise
Oct 17, 2025 4:01 AM

06:41 AM EDT, 10/17/2025 (MT Newswires) -- Comerica ( CMA ) reported Q3 earnings Friday of $1.35 per diluted share, up from $1.33 a year earlier.

Analysts polled by FactSet expected $1.31.

Revenue for the quarter ended Sept. 30, expressed as the sum of net interest income and total noninterest income, was $838 million, compared with $811 million a year earlier.

Analysts surveyed by FactSet expected $843.2 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Madison Pacific Properties Q4 Loss Narrows as Revenue Rises
Madison Pacific Properties Q4 Loss Narrows as Revenue Rises
Nov 4, 2024
07:11 AM EST, 11/04/2024 (MT Newswires) -- Madison Pacific Properties ( MDPCF ) , a Vancouver-based real estate company, over the weekend said its net loss for the fourth quarter narrowed as revenue rose. The net loss declined to $42,000 or $0.00 per share, from $6.8 million, or $0.12 per share, in the same quarter last year. Property revenue, which...
Hecla Mining Names Rob Krcmarov CEO, Carlos Aguiar COO
Hecla Mining Names Rob Krcmarov CEO, Carlos Aguiar COO
Nov 4, 2024
07:08 AM EST, 11/04/2024 (MT Newswires) -- Hecla Mining Company ( HL ) said Monday it appointed Rob Krcmarov as president and chief executive, effective Thursday. He succeeds Catherine J. Boggs, who served as interim president and chief executive since May 22, and will remain chair of the board of directors. Krcmarov will also join Hecla's board. The geologist and...
FDA approves Journey Medical's drug for long-term skin condition
FDA approves Journey Medical's drug for long-term skin condition
Nov 4, 2024
Nov 4 (Reuters) - The U.S. Food and Drug Administration has approved Journey Medical's ( DERM ) drug for the treatment of a long-term skin condition called rosacea, the company said on Monday. ...
Owens & Minor's Q3 Earnings Fall, Revenue Advances
Owens & Minor's Q3 Earnings Fall, Revenue Advances
Nov 4, 2024
07:07 AM EST, 11/04/2024 (MT Newswires) -- Owens & Minor ( OMI ) reported Q3 adjusted net income Monday of $0.42 per share, down from $0.44 a year earlier. Analysts polled by Capital IQ expected $0.41. Consolidated revenue for the quarter ended Sept. 30 was $2.72 billion, up from $2.59 billion a year earlier. Analysts surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved